Development of scalable, versatile, and cost-effective processes for iPSC-derived cell therapy manufacturing via linear scale-up (up to 80L) and high-density cell banking approaches

Conference Dates

February 1 – 5, 2026

Abstract

Please click Additional Files below to see the full abstract

This document is currently not available here.

Share

COinS